MERCK va bien pero...15.000 a la calle. (Hasta el 2012)

NEW YORK (Reuters) - Merck & Co posted quarterly revenue ahead of analysts' estimates on Tuesday, and stuck by its financial goals from its recently completed merger with rival drugmaker Schering-Plough Corp.

Its shares rose 1.7 percent as the drugmaker reported quarterly profit that matched Wall Street estimates.

"The numbers look broadly speaking right in line," Deutsche Bank analyst Barbara Ryan said. "Everything looks good and on track. People are going to be most interested in the 2010 guidance, but they're not going to give that yet."

Todo muy bien (?) pero...

"The new Merck is off to an excellent start," CEO Richard Clark commented.

.../...

"The drugmaker stood by its previous goal of $3.5 billion in annual cost savings in 2012 as it cuts 15 percent of jobs from the combined company. Merck had about 100,000 employees at the end of the year, and plans to slash about 2,500 vacant positions as part of the initial phase of the cost cuts."

Ver...